Middle East & Africa Flow Cytometry Market Size & Outlook

The flow cytometry market in Middle East & Africa is expected to reach a projected revenue of US$ 244.6 million by 2030. A compound annual growth rate of 5.2% is expected of Middle East & Africa flow cytometry market from 2025 to 2030.
Revenue, 2024 (US$M)
$179.5
Forecast, 2030 (US$M)
$244.6
CAGR, 2025 - 2030
5.2%
Report Coverage
Middle East & Africa

Middle East & Africa flow cytometry market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa flow cytometry market, 2018-2030 (US$M)

MEA flow cytometry market highlights

  • The MEA flow cytometry market generated a revenue of USD 179.5 million in 2024.
  • The market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
  • In terms of segment, instruments was the largest revenue generating product in 2024.
  • Software is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.

MEA data book summary

Market revenue in 2024USD 179.5 million
Market revenue in 2030USD 244.6 million
Growth rate5.2% (CAGR from 2025 to 2030)
Largest segmentInstruments
Fastest growing segmentSoftware
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents & Consumables, Software, Accessories, Services
Key market players worldwideDanaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp

Other key industry trends

  • In terms of revenue, MEA region accounted for 3.8% of the global flow cytometry market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,656.7 million by 2030.

Instruments was the largest segment with a revenue share of 37.27% in 2024. Horizon Databook has segmented the Middle East & Africa flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.


The flow cytometry market in this region is anticipated to exhibit steady growth during the forecast period. This steady growth can be attributed to factors such as limited investments in biotechnology sector, low affordability of expensive systems, and less R&D activities in pharmaceutical & biotechnology sectors.

However, robust government initiatives being undertaken to boost the biotechnology sector in countries such as Saudi Arabia and UAE are anticipated to create lucrative opportunities in the near future. Furthermore, increasing focus on hematology and oncology due to high prevalence of cancer and other diseases is anticipated to drive the demand for flow cytometry products for conducting research.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Flow Cytometry Market Companies

Name Profile # Employees HQ Website

MEA flow cytometry market size, by country, 2018-2030 (US$M)

Middle East & Africa Flow Cytometry Market Outlook Share, 2024 & 2030 (US$M)

MEA flow cytometry market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more